Download PDF
J Pediatr Infect Dis 2020; 15(05): 262-264
DOI: 10.1055/s-0040-1708512
Case Report

Humidification Solution as a Source for Spreading Burkholderia cepacia in a Neonatal Intensive Care Unit

Bora Baysal 
1   Department of Neonatology, Faculty of Medicine, Uşak University, Uşak, Turkey
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Burkholderia cepacia is an important opportunistic organism in hospitalized and immunocompromised patients especially in newborns. The natural ecology of these bacteria associated with plants is also a cause of infectious potential. The disease-causing potential of bacteria as a nosocomial pathogen may be due to its ability to survive in antiseptic solutions, contamination equipment. The patient was hospitalized for prematurity and respiratory distress syndrome. He was treated with surfactant intratracheally for the respiratory distress syndrome. Umbilical catheter was inserted. Ampicillin and gentamicin treatments were initiated. The patient who received respiratory support for a long time was given a steroid protocol because of bronchopulmonary dysplasia. Burkholderia cepacia was detected in the blood and tracheal aspirate cultures of the patient, whose infection markers increased and a new area of infection was detected on the chest radiograph. Colistin and ciprofloxacin treatments were given according to the culture antibiogram. Screening tests revealed B. cepacia colonization in incubator moistening solutions. All incubator humidification solutions in the hospital were changed. Burkholderia cepacia is a rare cause of nosocomial infection in intensive care units but resistant to many treatments. With its capability to colonize water and grow on microbicides, the presence of B. cepacia in a patient's blood warrants further investigation in institutions providing care.

Keywords

Burkholderia cepacia - neonatology - prematurity - humidification solution


Publication History

Received: 13 November 2019

Accepted: 13 February 2020

Article published online:
13 March 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York

 

  • References

  • 1 Karanth SS, Regunath H, Chawla K, Prabhu M. A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual. Asian Pac J Trop Biomed 2012; 2 (02) 166-168
    CrossrefPubMedGoogle Scholar
  • 2 Chiarini L, Bevivino A, Dalmastri C, Tabacchioni S, Visca P. Burkholderia cepacia complex species: health hazards and biotechnological potential. Trends Microbiol 2006; 14 (06) 277-286
    CrossrefPubMedGoogle Scholar
  • 3 Crispim JN, Dâmaso C, Marques JG, Miguéns J, Valente P. Burkholderia cepacia meningitis: a case report. J Pediatr Infect Dis 2010; 5 (04) 393-396
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Gautam V, Arora A, Madhup SK. , et al. Burkholderia cepacia complex in septicaemic non-cystic fibrosis cases from two tertiary care hospitals in north India. Indian J Med Res 2010; 131 (06) 829-832
    PubMedGoogle Scholar
  • 5 Matthaiou DK, Chasou E, Atmatzidis S, Tsolkas P. A case of bacteremia due to Burkholderia cepacia in a patient without cystic fibrosis. Respir Med CME 2011; 4 (03) 144-145
    CrossrefPubMedGoogle Scholar
  • 6 Sousa SA, Ramos CG, Leitão JH. Burkholderia cepacia complex: emerging multihost pathogens equipped with a wide range of virulence factors and determinants. Int J Microbiol 2011; 2011: x
    CrossrefPubMedGoogle Scholar
  • 7 Gade N, Negi SS, Jindal A, Gaikwad U, Das P, Bhargava A. Dual lower respiratory tract infection by Burkholderia cepacia and Acinetobacter baumannii in a neonate: a case report. J Clin Diagn Res 2016; 10 (10) DD01-DD03
    PubMedGoogle Scholar
  • 8 Paul LM, Hegde A, Pai T, Shetty S, Baliga S, Shenoy S. An outbreak of Burkholderia cepacia bacteremia in a neonatal intensive care unit. Indian J Pediatr 2016; 83 (04) 285-288
    CrossrefPubMedGoogle Scholar
  • 9 Darmstadt GL, Kinney MV, Chopra M. , et al; Lancet Every Newborn Study Group. Who has been caring for the baby?. Lancet 2014; 384 (9938): 174-188
    CrossrefPubMedGoogle Scholar
  • 10 Seale AC, Blencowe H, Manu AA. , et al; pSBI Investigator Group. Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14 (08) 731-741
    CrossrefPubMedGoogle Scholar
  • 11 Agarwal R, Sankar J. ; Investigators of the Delhi Neonatal Infection Study (DeNIS) collaboration. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. Lancet Glob Health 2016; 4 (10) e752-e760
    CrossrefPubMedGoogle Scholar
  • 12 Basha S, Surendran N, Pichichero M. Immune responses in neonates. Expert Rev Clin Immunol 2014; 10 (09) 1171-1184
    CrossrefPubMedGoogle Scholar